Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Nature, 402 (6762), 656660
Key benefits Why people compare it 1 FDA-approved as Egrifta for visceral adipose tissue reduction in lipodystrophy 2 15-18% VAT reduction demonstrated in two Phase 3 trials (N=816) 3 Improved triglycerides and waist circumference in key clinical data 4 Extended half-life (26-38 min) vs sermorelin due to trans-3-hexenoic acid modification 5 Improved verbal memory and executive function in older adults (Neurology study, p=0.03) 6 Physiological GH stimulation with intact pituitary negative feedback 7 Demonstrated 32% hepatic fat reduction in 12-month NAFLD trial 8 Well-characterized safety profile through FDA approval and post-marketing surveillance Deep research About Tesamorelin Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH) consisting of all 44 amino acids of native GHRH with a trans-3-hexenoic acid moiety conjugated to the tyrosine residue at position 1 via a carbamate linker
My legs are heavy body akes and I feel rough
Earlier in the diabetes treatment progression
Although BPC-157 is backed by research to be a potential therapeutic for many conditions, it is imperative to note that these are only preclinical studies
Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery
